Understanding the Purity and Specifications of CAS 53716-49-7 for Pharmaceutical Applications
The pharmaceutical industry places an uncompromising emphasis on the purity and precise specifications of its raw materials. For compounds like CAS 53716-49-7, a crucial component in the synthesis of veterinary anti-inflammatory drugs, these standards are non-negotiable. As a leading pharmaceutical intermediate 53716-49-7, its quality directly influences the efficacy and safety of the final drug product used for NSAID for animal pain relief.
The typical specifications for this compound highlight a minimum purity of 99.00%. This high level of purity ensures that unwanted side reactions are minimized during the synthesis of the active pharmaceutical ingredient, and that the final product is free from contaminants that could compromise its therapeutic action or patient safety. Furthermore, understanding the physical properties, such as its appearance as a 'White to beige crystalline solid', and its melting point (186-188 °C), provides vital information for handling, storage, and processing within pharmaceutical manufacturing facilities.
For entities looking to buy pharmaceutical intermediate 53716-49-7, sourcing from reputable suppliers is paramount. A trusted carprofen CAS 53716-49-7 supplier will provide comprehensive documentation, including Certificates of Analysis (CoA) that verify the compound meets all specified quality parameters. This transparency is fundamental in the regulated environment of pharmaceutical manufacturing. The consistent quality of an anti-inflammatory drug intermediate directly translates to predictable outcomes in drug formulation and bio-availability.
The role of this veterinary NSAID CAS 53716-49-7 extends to managing pain and inflammation in various animal conditions. Accurate specifications ensure that the drug's pharmacological profile remains consistent, enabling veterinarians to administer effective treatment for joint pain, arthritis, and post-operative recovery. By adhering to strict quality control, manufacturers can confidently produce high-performance veterinary medications that meet the growing demands for animal healthcare.
Perspectives & Insights
Molecule Vision 7
“This transparency is fundamental in the regulated environment of pharmaceutical manufacturing.”
Alpha Origin 24
“The consistent quality of an anti-inflammatory drug intermediate directly translates to predictable outcomes in drug formulation and bio-availability.”
Future Analyst X
“The role of this veterinary NSAID CAS 53716-49-7 extends to managing pain and inflammation in various animal conditions.”